LMR Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$561K Buy
+50,699
New +$310K ﹤0.01% 1155
2025
Q3
Sell
-50,000
Closed -$465K 1616
2025
Q2
$465K Buy
+50,000
New +$436K ﹤0.01% 966
2024
Q4
Sell
-82,479
Closed -$904K 1536
2024
Q3
$904K Buy
82,479
+48,920
+146% +$497K 0.01% 757
2024
Q2
$302K Buy
+33,559
New +$234K ﹤0.01% 816
2024
Q1
Sell
-1
Closed -$8 1282
2023
Q4
$8 Buy
+1
New +$12 ﹤0.01% 973

Other funds holding REPL

LMR Partners's REPL Position: Q2 2026 in Review

LMR Partners opened a new position in Replimune Group (REPL) in Q2 2026: 50,699 shares worth $561K. The stake represents ﹤0.01% of the portfolio and ranks #1155 among its holdings. This is a return to the name: LMR Partners previously reported a position in REPL as recently as Q2 2025.

LMR Partners first reported a position in REPL in Q4 2023 and has held it in 5 quarters since. The position peaked at $904K in Q3 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • LMR Partners held 50,699 shares of Replimune Group worth $561K as of Q2 2026.
  • Replimune Group was a new LMR Partners position in Q2 2026.
  • Replimune Group made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1155 holding.
  • LMR Partners first reported a position in Replimune Group in Q4 2023 and has held it in 5 quarters since.
  • LMR Partners's Replimune Group position peaked at $904K in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.